Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 Disease)

J. P. Dyke, D. Sondhi, H. U. Voss, K. Yohay, C. Hollmann, D. Mancenido, S. M. Kaminsky, L. A. Heier, K. D. Rudser, B. Kosofsky, B. J. Casey, R. G. Crystal, D. Ballon

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


BACKGROUND AND PURPOSE: Late infantile neuronal ceroid lipofuscinosis (CLN2 disease) is a uniformly fatal lysosomal storage disease resulting from mutations in the CLN2 gene. Our hypothesis was that regional analysis of cortical brain degeneration may identify brain regions that are affected earliest and most severely by the disease. MATERIALS AND METHODS: Fifty-two high-resolution 3T MR imaging datasets were prospectively acquired on 38 subjects with CLN2. A retrospective cohort of 52 disease-free children served as a control population. The FreeSurfer software suite was used for calculation of cortical thickness. RESULTS: An increased rate of global cortical thinning in CLN2 versus control subjects was the primary finding in this study. Three distinct patterns were observed across brain regions. In the first, subjects with CLN2 exhibited differing rates of cortical thinning versus age. This was true in 22 and 26 of 34 regions in the left and right hemispheres, respectively, and was also clearly discernable when considering brain lobes as a whole and Brodmann regions. The second pattern exhibited a difference in thickness from healthy controls but with no discernable change with age (9 left hemispheres, 5 right hemispheres). In the third pattern, there was no difference in either the rate of cortical thinning or the mean cortical thickness between groups (3 left hemispheres, 3 right hemispheres). CONCLUSIONS: This study demonstrates that CLN2 causes differential rates of degeneration across the brain. Anatomic and functional regions that degenerate sooner and more severely than others compared with those in healthy controls may offer targets for directed therapies. The information gained may also provide neurobiologic insights regarding the mechanisms underlying disease progression.

Original languageEnglish (US)
Pages (from-to)1160-1169
Number of pages10
JournalAmerican Journal of Neuroradiology
Issue number6
StatePublished - Jun 2016

Bibliographical note

Funding Information:
This work was supported in part by grants from the National Institutes of Health (R01NS061848, U54NS065768). The Lysosomal Disease Network (U54NS065768) is a part of the National Center for Advancing Translational Sciences Rare Diseases Clinical Research Network, an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences, funded through a collaboration among the National Center for Advancing Translational Sciences, National Institute of Neurological Disorders and Stroke, and National Institute of Diabetes and Digestive and Kidney Diseases.


Dive into the research topics of 'Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 Disease)'. Together they form a unique fingerprint.

Cite this